Company Overview of Nucleonics, Inc.
Nucleonics, Inc., a biotechnology company, develops RNAi therapeutics for viral and other diseases. It offers NUC-B1000, a hepatitis B antiviral agent. The company also focuses on the development of eiRNA-based therapeutics for chronic hepatitis B and hepatitis C infections. Nucleonics, Inc. was founded in 2001 and is based in Langhorne, Pennsylvania.
13 Summit Square Center
Langhorne, PA 19047-1098
Founded in 2001
Key Executives for Nucleonics, Inc.
Similar Private Companies By Industry
|Synthetic Genomics Vaccines Inc||United States|
|Santalis Pharmaceuticals, Inc.||United States|
|Theron Pharmaceuticals, Inc.||United States|
|American Sterilizer Company||United States|
|Cytonome, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Germany, PA | Life TechnologiesPosted: Nov 22
- Frederick, MD | Computer Sciences Corporation (CSC)Posted: Nov 26
- Billerica, MA | Mergis Group, A Division of SpherionPosted: Dec 10
- Emeryville, CA | A10Posted: Dec 11
Sponsored Financial Commentaries
To contact Nucleonics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.